文献速递脑血管病

孤立性大脑后动脉闭塞的血管内治疗或单纯药物治疗:一项多中心研究

Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study.
PubMed 文献 · Stroke · 2023-02-02

这项国际多中心观察性研究纳入26个卒中中心发病6小时内的752例孤立性大脑后动脉P1或P2段闭塞患者,比较最佳药物治疗联合血管内治疗与单纯最佳药物治疗。经倾向评分加权后,血管内治疗与良好功能结局呈较低优势趋势(OR 0.81,95%CI 0.66-1.01;P=0.06),与优良功能结局无关(OR 1.17,95%CI 0.95-1.43;P=0.15),但与症状性颅内出血(OR 2.51,95%CI 1.35-4.67;P=0.004)和早期神经功能恶化(OR 2.51,95%CI 1.64-3.84;P<0.0001)风险升高相关。

要点

  • 血管内治疗与良好功能结局呈较低优势趋势(OR 0.81,95%CI 0.66-1.01;P=0.06),未达统计学显著。
  • 血管内治疗与优良功能结局无关(OR 1.17,95%CI 0.95-1.43;P=0.15)。
  • 血管内治疗与症状性颅内出血(OR 2.51)和早期神经功能恶化(OR 2.51)风险升高相关。

核心结论

  • 在这项近端大脑后动脉闭塞患者的观察性研究中,与单纯最佳药物治疗相比,血管内治疗与良好或优良功能结局无关。
  • 然而,血管内治疗与更高的症状性颅内出血和早期神经功能恶化发生率相关。
  • 作者认为,该人群不应常规推荐血管内治疗,但非常有必要开展随机对照临床试验。

研究设计与样本

  • 多中心国际观察性研究,连续纳入26个卒中中心发病6小时内孤立性大脑后动脉第一段(P1)或第二段(P2)闭塞的卒中患者。
  • 患者接受最佳药物治疗联合血管内治疗或单纯最佳药物治疗。
  • 采用倾向评分逆概率治疗加权校正组间基线差异。
  • 共纳入752例患者,其中最佳药物治疗联合血管内治疗组167例,单纯最佳药物治疗组585例。

主要发现

  • 中位年龄74岁(四分位距63-82岁),女性329例(44%),中位美国国立卫生研究院卒中量表评分6分(四分位距4-10分)。
  • 闭塞部位为P1段188例(25%),P2段564例(75%)。
  • 倾向评分加权后两组基线临床和影像学数据相似。
  • 血管内治疗与良好功能结局呈较低优势趋势(OR 0.81,95%CI 0.66-1.01;P=0.06),与优良功能结局无关(OR 1.17,95%CI 0.95-1.43;P=0.15)。
  • 血管内治疗与症状性颅内出血风险升高相关(OR 2.51,95%CI 1.35-4.67;P=0.004),与早期神经功能恶化风险升高相关(OR 2.51,95%CI 1.64-3.84;P<0.0001)。

临床怎么用

  • 作者认为,该人群不应常规推荐血管内治疗,但非常有必要开展随机对照临床试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether endovascular therapy (EVT) added on best medical management (BMM), as compared to BMM alone, is beneficial in acute ischemic stroke with isolated posterior cerebral artery occlusion is unknown. METHODS: We conducted a multicenter international observational study of consecutive stroke patients admitted within 6 hours from symptoms onset in 26 stroke centers with isolated occlusion of the first (P1) or second (P2) segment of the posterior cerebral artery and treated either with BMM+EVT or BMM alone. Propensity score with inverse probability of treatment weighting was used to account for baseline between-groups differences. The primary outcome was 3-month good functional outcome (modified Rankin Scale [mRS] score 0-2 or return to baseline modified Rankin Scale). Secondary outcomes were 3-month excellent recovery (modified Rankin Scale score 0-1), symptomatic intracranial hemorrhage, and early neurological deterioration. RESULTS: Overall, 752 patients were included (167 and 585 patients in the BMM+EVT and BMM alone groups, respectively). Median age was 74 (interquartile range, 63-82) years, 329 (44%) patients were female, median National Institutes of Health Stroke Scale was 6 (interquartile range 4-10), and occlusion site was P1 in 188 (25%) and P2 in 564 (75%) patients. Baseline clinical and radiological data were similar between the 2 groups following propensity score weighting. EVT was associated with a trend towards lower odds of good functional outcome (odds ratio, 0.81 [95% CI, 0.66-1.01]; P=0.06) and was not associated with excellent functional outcome (odds ratio, 1.17 [95% CI, 0.95-1.43]; P=0.15). EVT was associated with a higher risk of symptomatic intracranial hemorrhage (odds ratio, 2.51 [95% CI, 1.35-4.67]; P=0.004) and early neurological deterioration (odds ratio, 2.51 [95% CI, 1.64-3.84]; P<0.0001). CONCLUSIONS: In this observational study of patients with proximal posterior cerebral artery occlusion, EVT was not associated with good or excellent functional outcome as compared to BMM alone. However, EVT was associated with higher rates of symptomatic intracranial hemorrhage and early neurological deterioration. EVT should not be routinely recommended in this population, but randomization into a clinical trial is highly warranted.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Sabben C, Charbonneau F, Delvoye F, et al. Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study. Stroke. 2023. PMID: 36729389. doi:10.1161/STROKEAHA.122.042283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。